Following the testing of therapeutic sera, the quantified evaluation of a pharmaceutical's efficacy became a key feature of medicine in the twentieth century. The case studies in this volume offer comparisons across Europe, from the diphtheria antitoxin in the late 1800s to the introduction of the Salk polio vaccine in the 1950s.
Based on extensive archival research, this study examines the role of the Rockefeller Foundation and the League of Nations in improving public health during the interwar period. Barona argues that the Foundation applied a model of business efficiency to its ideology of spreading good health, creating a revolution in public health practice.
When asked to compare the practice of medicine today to that of a hundred years ago, most people will respond with a story of therapeutic revolution: Back then we had few effective remedies, but now we have more (and more powerful) tools to fight disease, from antibiotics to psychotropics to steroids to anticancer agents. This collection challenges the historical accuracy of this revolutionary narrative and offers instead a more nuanced account of the process of therapeutic innovation and the relationships between the development of medicines and social change. These assembled histories and ethnographies span three continents and use the lived experiences of physicians and patients, consumers and providers, and marketers and regulators to reveal the tensions between universal claims of therapeutic knowledge and the actual ways these claims have been used and understood in specific sites, from postwar West Germany pharmacies to twenty-first century Nigerian street markets. By asking us to rethink a story we thought we knew, Therapeutic Revolutions offers invaluable insights to historians, anthropologists, and social scientists of medicine.
The global pharmaceutical industry is currently estimated to be worth $1 trillion. Contributors chart the rise of scientific marketing within the industry from 1920-1980. This is the first comprehensive study into pharmaceutical marketing, demonstrating that many new techniques were actually developed in Europe before being exported to America.
The use of biologics – drugs made from living organisms – has raised specific scientific, industrial, medical and legal issues. The essays contained in this collection each deal with a case study of a biologic substance, or group of biologics, and its use during the twentieth century.
The Routledge History of Disease draws on innovative scholarship in the history of medicine to explore the challenges involved in writing about health and disease throughout the past and across the globe, presenting a varied range of case studies and perspectives on the patterns, technologies and narratives of disease that can be identified in the past and that continue to influence our present. Organized thematically, chapters examine particular forms and conceptualizations of disease, covering subjects from leprosy in medieval Europe and cancer screening practices in twentieth-century USA to the ayurvedic tradition in ancient India and the pioneering studies of mental illness that took place in nineteenth-century Paris, as well as discussing the various sources and methods that can be used to understand the social and cultural contexts of disease. Chapter 24 of this book is freely available as a downloadable Open Access PDF under a Creative Commons Attribution-Non Commercial-No Derivatives 3.0 license. https://www.routledgehandbooks.com/doi/10.4324/9781315543420.ch24
Drugs are considered to be healers and harmers, wonder substances and knowledge makers; objects that impact on social hierarchies, health practices and public policies. As a collective endeavour, this book focuses on the ways that gender, along with race/ethnicity and class, influence the design, standardisation and circulation of drugs throughout several highly medicalised countries throughout the twentieth century and until the twenty-first. Fourteen authors from different European and non-European countries analyse the extent to which the dominant ideas and values surrounding masculinity and femininity have contributed to shape the research, prescription and use of drugs by women and men within particular social and cultural contexts. New and lesser-known, gender-specific issues in lifestyles and social practices associated with pharmaceutical technologies are analysed, as is the manner in which they intervene in life experiences such as reproduction, sexual desire, childbirth, depression and happiness. The processes of prescribing, selling, marketing and accepting or forbidding drugs is also examined, as is the contribution of gendered medical practices to the medicalisation and growing consumption of drugs by women. Gender relations and other hierarchies are involved as both causes and consequences of drug cultures, and of the history and social life of gender in contemporary drug production, use and consumption. A network of agents emerges from this book’s research, contributing to a better understanding of both gender and drugs within our society.
This book reveals the ever-present challenges of patient care at the forefront of medical knowledge. Syphilis and gonorrhoea played upon the public imagination in Victorian and Edwardian England, inspiring fascination and fear. Seemingly inextricable from the other great 'social evil', prostitution, these diseases represented contamination, both physical and moral. They infiltrated respectable homes and brought terrible suffering and stigma to those afflicted. Medicine, Knowledge and Venereal Diseases takes us back to an age before penicillin and the NHS, when developments in pathology, symptomology and aetiology were transforming clinical practice. This is the first book to examine systematically how doctors, nurses and midwives grappled with new ideas and laboratory-based technologies in their fight against venereal diseases in voluntary hospitals, general practice and Poor Law institutions. It opens up new perspectives on what made competent and safe medical professionals; how these standards changed over time; and how changing attitudes and expectations affected the medical authority and autonomy of different professional groups.
Blood is messy, dangerous, and charged with meaning. By following it as it circulates through people and institutions, Jenny Bangham explores the intimate connections between the early infrastructures of blood transfusion and the development of human genetics. Focusing on mid-twentieth-century Britain, Blood Relations connects histories of eugenics to the local politics of giving blood, showing how the exchange of blood carved out networks that made human populations into objects of medical surveillance and scientific research. Bangham reveals how biology was transformed by two world wars, how scientists have worked to define racial categories, and how the practices and rhetoric of public health made genetics into a human science. Today, genetics is a powerful authority on human health and identity, and Blood Relations helps us understand how this authority was achieved.
